Genor Biopharma Holdings Limited

HKEX:6998.HK

1.65 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q1
Operating Activities:
Net Income -62.848-62.848-199.905-199.905-137.276-137.276-162.292-162.292-202.816-202.816-232.166-232.166-200.447-200.447-1,246.859-1,246.859-391.42-143.556-74.317
Depreciation & Amortization 0024.57122.22913.87313.87311.50811.50814.07414.07414.32214.32215.02115.02112.92112.92111.96411.2669.552
Deferred Income Tax 000000-58.648-1.3550000000001.6110
Stock Based Compensation 2.4522.45211.88611.88618.56918.5693.7073.70720.41220.41221.95321.95345.18445.18436.42536.425157.64427.1310
Change In Working Capital 00-7.639-7.6390039.14739.14700-4.594-4.59400-101.192-101.1921.1428.385-9.58
Accounts Receivables 0000000000000000000.042
Change In Inventory 003.9533.95300-2.353-2.35300-11.17-11.1700-3.83-3.83-1.671.67-3.025
Change In Accounts Payables 0000000000000000000
Other Working Capital 00-11.592-11.5920041.49941.499006.5766.57600-97.362-97.3622.8126.715-6.555
Other Non Cash Items 60.39660.39673.87376.216-10.512-10.512-24.77-24.7712.22712.22741.79641.796-12.939-12.9391,117.8441,117.844-109.062-0.098-0.289
Operating Cash Flow 00-97.214-97.214-115.346-115.346-132.7-132.7-156.104-156.104-158.69-158.69-153.181-153.181-180.861-180.861-329.732-95.261-74.634
Investing Activities:
Investments In Property Plant And Equipment 000.3760.376-0.893-0.8930.2120.212-4.732-4.732-9.787-9.787-13.448-13.448-9.48-9.48-3.926-8.209-7.708
Acquisitions Net 00003.10-0.147000000000000
Purchases Of Investments 0000000000000000000
Sales Maturities Of Investments 0000000000000000000
Other Investing Activites 002.142.141.3711.371-1.503-1.503-0.448-0.448-1.442-1.442-2.454-2.454-34.291-34.2911.3930.04-0.13
Investing Cash Flow 002.5162.5160.4780.478-1.291-1.291-5.18-5.18-11.228-11.228-15.902-15.902-43.771-43.771-2.533-8.169-7.708
Financing Activities:
Debt Repayment 0000000000000000106.05313.928-1.16
Common Stock Issued 00000000000000000.00734.8590
Common Stock Repurchased 000000-0.124-0.124-2.443-2.443000000000
Dividends Paid 0000000000000000000
Other Financing Activities 00-1.531-1.531-1.88-1.88-7.282-7.282-18.847-18.84711.05111.051-2.265-2.2651,288.1991,288.1991,009.731-2.594-0.55
Financing Cash Flow 00-1.531-1.531-1.88-1.88-7.406-7.406-21.29-21.2911.05111.051-2.265-2.2651,288.1991,288.1991,115.79146.193-1.71
Other Information:
Effect Of Forex Changes On Cash 00-2.016-2.0163.3823.3826.6596.65911.34311.343-30.387-30.387-3.95-3.95-95.162-95.16212.5710.553-0.017
Net Change In Cash 00-98.245-98.245-314.381-113.367-394.427-134.738-171.23-171.23-189.254-189.254-175.297-175.297968.405968.405796.097-56.684-84.069
Cash At End Of Period 00-98.245-98.2451,469.321-113.3671,783.7021,723.4431,858.181-171.23-189.2542,389.8952,579.149-175.297968.4051,961.338992.933196.83641.089